Complementary use of the DNA methylation-based tumor classification by the Bethesda v3 classifier in routine diagnostics: evaluation in a series of 516 cases.
- DOI
- 10.1007/s00401-026-03079-2
- Published
- 2026 Sep 15
- Container
- Acta neuropathologica
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00401-026-03079-2,
title = {Complementary use of the DNA methylation-based tumor classification by the Bethesda v3 classifier in routine diagnostics: evaluation in a series of 516 cases.},
author = {Brandenburg C and Starzetz T and Woltering N and Kumar A and Münzberg M and Wenger KJ and Plate KH and Singh O and Aldape KD and Schweizer L},
year = {2026},
journal = {Acta neuropathologica},
doi = {10.1007/s00401-026-03079-2},
url = {https://doi.org/10.1007/s00401-026-03079-2}
}RIS
TY - JOUR TI - Complementary use of the DNA methylation-based tumor classification by the Bethesda v3 classifier in routine diagnostics: evaluation in a series of 516 cases. AU - Brandenburg C AU - Starzetz T AU - Woltering N AU - Kumar A AU - Münzberg M AU - Wenger KJ AU - Plate KH AU - Singh O AU - Aldape KD AU - Schweizer L PY - 2026 JO - Acta neuropathologica DO - 10.1007/s00401-026-03079-2 UR - https://doi.org/10.1007/s00401-026-03079-2 ER -
APA
C, B., T, S., N, W., A, K., M, M., KJ, W., KH, P., O, S., KD, A., & L, S. (2026). Complementary use of the DNA methylation-based tumor classification by the Bethesda v3 classifier in routine diagnostics: evaluation in a series of 516 cases.. Acta neuropathologica. https://doi.org/10.1007/s00401-026-03079-2
Source records
- pubmed · retrieved 2026-11-10T12:08:28.353Z